Tissue distribution of propafenone in the rat after intravenous administration. 1991

J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
Department of Pharmacology, Veterinary Faculty, Universitat Autònoma de Barcelona, Spain.

Tissue distribution of propafenone has been studied in the rat. Measurement of propafenone was made in several tissues: plasma, heart, kidney, lung, liver, muscle, fat and brain, after i.v. administration of 2 mg/kg of the drug. The plasma propafenone kinetics profile can be described by a two-compartmental model. The pharmacokinetic parameters, derived from plasma levels, showed a t1/2 beta of 55.4 min, the central Vd/kg of 2.4 ml/kg, the Cl of 62.8 ml/min.kg and the AUC0-oo of 31.6 micrograms.min/ml. The analysis of the propafenone tissue distribution showed the highest concentration of drug in the lung, followed by the heart and kidneys. A significant concentration was found in brain, muscle and adipose tissue, with concentration ratios (tissue/plasma) above 1. The half-life values obtained for individual organs and tissues are similar to those obtained in plasma, around 1 h. In the post-distributive phase, plasma and tissue concentrations decline in parallel.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat

Related Publications

J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
May 1992, Journal of the American College of Cardiology,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
December 1987, Journal of veterinary pharmacology and therapeutics,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
July 1997, Acta radiologica (Stockholm, Sweden : 1987),
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
December 1981, Journal of pharmacokinetics and biopharmaceutics,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
January 2013, Pharmacological reports : PR,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
August 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
October 1973, Anesthesiology,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
April 2014, Archives of pharmacal research,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
January 2004, Arzneimittel-Forschung,
J Fernández, and L Lligoña, and A Puigdemont, and R Guitart, and J L Riu, and M Arboix
January 2002, Japanese journal of pharmacology,
Copied contents to your clipboard!